Agios Pharmaceuticals, Inc. is a biopharmaceutical company that pioneers therapies for rare diseases, with a focus on hemolytic anemias. The company is committed to building connections and cultivating relationships to create life-changing therapies for patients with rare diseases.

Agios Pharmaceuticals, Inc.

Agios Pharmaceuticals Inc is a biopharmaceutical company with a focus on developing treatments geared towards cancer and rare genetic disorders of metabolism. The company's primary focus is to develop potentially transformative small-molecule medicines. The clinical development plan for Agios' product candidates includes a precision approach with initial study designs that allow for genetically or biomarker-defined patient populations. The company seeks the potential for proof of concept early in clinical development, along with any potential for accelerated approval.

COM:AGIOS

Agios Pharmaceuticals, Inc.

Last Close

55.54

22/11 21:00

Market Cap

2.02B

Beta: -

Volume Today

419.15K

Avg: -

name

homepage url

country

crunchbase url

employee count

sector

industry

revenue

Description

peer of

competitor of

Metrics